Aisling Capital as of Sept. 30, 2015
Portfolio Holdings for Aisling Capital
Aisling Capital holds 22 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zeltiq Aesthetics | 14.7 | $83M | 2.6M | 32.03 | |
| Aimmune Therapeutics | 12.6 | $71M | 2.8M | 25.32 | |
| Cempra | 10.7 | $61M | 2.2M | 27.84 | |
| Loxo Oncology | 10.6 | $60M | 3.5M | 17.48 | |
| Esperion Therapeutics (ESPR) | 6.8 | $39M | 1.6M | 23.59 | |
| Adma Biologics (ADMA) | 5.3 | $30M | 3.6M | 8.36 | |
| Chimerix (CMRX) | 4.9 | $28M | 723k | 38.20 | |
| Versartis | 4.6 | $26M | 2.3M | 11.53 | |
| Dermira | 4.5 | $26M | 1.1M | 23.34 | |
| T2 Biosystems | 3.9 | $22M | 2.5M | 8.76 | |
| Agile Therapeutics | 3.5 | $20M | 3.0M | 6.74 | |
| Transenterix | 3.3 | $19M | 8.3M | 2.26 | |
| Catalent (CTLT) | 3.1 | $17M | 716k | 24.30 | |
| Cynapsus Therapeutics | 2.8 | $16M | 975k | 16.17 | |
| Paratek Pharmaceuticals | 2.3 | $13M | 683k | 19.00 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.3 | $13M | 1.0M | 12.72 | |
| Intersect Ent | 1.4 | $8.2M | 350k | 23.40 | |
| Pernix Therapeutics Holdings | 1.1 | $6.4M | 2.0M | 3.16 | |
| Lombard Med (EVARF) | 0.6 | $3.2M | 886k | 3.57 | |
| Sorrento Therapeutics (SRNE) | 0.5 | $3.0M | 354k | 8.39 | |
| Pernix Therapeutics Hldgs In debt | 0.3 | $1.8M | 2.5M | 0.72 | |
| Roka Bioscience | 0.3 | $1.6M | 812k | 1.95 |
